Remegen Co., Ltd.

This early-stage trial tests an experimental drug called RC148, given as an injection, in people with advanced non-small cell lung cancer that has spread. The study looks at how well the drug shrinks tumors, either alone or combined with other treatments. About 121 adults aged 18…

This study tests a drug called telitacicept in 318 adults with IgA nephropathy, a kidney disease that can lead to kidney failure. Participants are at high risk of worsening despite standard blood pressure medications. The goal is to see if telitacicept can reduce protein in the u…

This study tests a new drug (RC48-ADC) combined with immunotherapy (toripalimab) and either chemotherapy or another targeted drug (trastuzumab) as a first treatment for people with advanced stomach cancer. About 201 adults aged 18-75 with HER2-positive or HER2-negative stomach ca…